Comparative study of angiotensin converting enzyme inhibitor and calcium channel blocker in the treatment of steroid-resistant idiopathic nephrotic syndrome

Journal of Association of Physicians of India

Volumn 52, Issue JUN, 2004, Pages 454-458

  Kumar, N S ^a   Singh, A K ^a   Mishra, R N ^a   Prakash, J ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOCORTICOID; PREDNISOLONE; RAMIPRIL; VERAPAMIL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CHILD; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PREDNISOLONE; RAMIPRIL; VERAPAMIL;

EID: 13844320585     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cameron JS, Turner DR, Ogg CS, Chantler C, William DG. The long-term prognosis of patients with focal segmental glomerulosclerosis. Clinical Nephrol 1978;10:213-218.
2. Cameron JS, Turner DR, Heaton J, William DG, et al. Idiopathic mesangiocapillary glomerulonephritis: comparison of type 1 and 2 in children and adult and long term prognosis. Am J Med 1983;74:175-192.
3. Gansevoort RT, de Jong PE. Additive anti-proteinuria effect of ACE inhibition and a low protein diet in human renal disease. Nephrol Dial Transplant 1995;10:497-504.
4. Hemmelder MH, de Zeeruw D, Gansevoort RT, de Jong PE. Blood pressure reduction initiates the antiproteinuric effect of ACE inhibition. Kidney Int 1996;49:174-80.
5. Munter K, Hergenroder S, Joehims K, Kirchengast M. Individual and combined effects of verapamil or trandolapril on glomerular morphology and function in the stroke prone rat. J Am Soc Nephrol 1996;7:681-686.
6. Tarif, Bakris GS. Preservation of renal function: the spectrum of effects by calcium channel blocker. Nephrol Dial Transplant 1997;12:2244-50.
7. Bakris GL, Weir MR, De Quattro V, Mc Mohan FG. Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy. Kidney Int 1998;54:1283-89.
8. Giuserre M, Daniele A, Gerard J, et al. the angiotensinconverting enzyme inhibitor on progressive renal insufficiency. Engl J Med 1996;334:939-45.
9. Peterson JC, Adler S, Burkart J, et al. Blood pressure control, proteinuria and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 1995;l23:754-762.
10. Locatelli F, Carbarns M, Mascleia G, et al. Long term progression of chronic renal insufficiency in the AIPRI extension study. The angiotensin-converting enzyme inhibition on progressive renal insufficiency study group. Kidney Int 1997;52(suppl 63):563-566.
11. The GISEN Group (Grupp Italiano di study Epidemiologici in Nephrologia). Randomized placebo controlled trial of effect of ramipril in decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy (REIN study). Lancet, 1997; 349: 1857-63.
12. Ruggenenti P, Perne A, Gherard G, et al. (REIN study). Renoprotective properties of ACE inhibitor in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999;354:359-64.
13. Burton C, and Harris KPG. The role of proteinuria in the progression of chronic renal failure. Am J Kid Dis 1996;27:765-75.
14. Toto RD, Adams Huet B, Fenues AZ, Mitchell HC, Mulcahy W, Smith RD. Effect of ramipril on blood pressure and protein excretion rate in normotensive non diabetic patients with proteinuria. Am J Kid Dis 1996;28:832-40.
15. Prasher PK, Varma PP, Baliga KV. Efficiency of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome. J Assoc Phys India 1999;47:180-182.
16. Bakris GL, Copley JB, Vicknair N, Sadler R, Leurgans S. Calcium channel blockers versus other anti-hypertensive therapies on progression of NIDDM associated nephropathy. Kidney Int 1996;50:1641-50.